Skip to main content

Advertisement

Table 2 Summary of glycemic control studies

From: Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome

Article Design Patient Intervention or exposure Comparison Outcome Main results
Thiele RH 2009 [52] Single-center
Before–after study
Patients with the primary diagnosis of SAH 5.0–6.7 mmol/l
(90-120 mg/dl)
N = 491
No detail described
N = 343
In-hospital mortality Three was no significant difference in in-hospital mortality.
Latorre JG 2009 [53] Single-center
Before–after study
SAH patients with blood glucose > 11.1 mmol/l (200 mg/dl) on admission or the first 24 h mean blood glucose > 7.8 mmol/l (140 mg/dL) 4.4–7.8 mmol/l
(80-140 mg/dl)
N = 166
 11.1 mmol/l
(200 mg/dl)
N = 166
mRS  4 at 3–6 months Given temporal trend, there was no significant difference in neurological outcome.
Bilotta F. 2007 [54] Single-center, randomized control trial SAH patients undergoing emergency cerebral aneurysm clipping 4.4–6.7 mmol/l
(80–120 mg/dl)
N = 40
4.4–12.2 mmol/l
(80–220 mg/d)
N = 38
mRS  4 at 6 months (as secondary outcome) There was no significant difference in neurological outcome.
  1. mRS modified Ranking Scale score